TJC

Co-Chief Executive Officers Paul Sprague and Erik Fagan lead the firm alongside a partnership group that includes senior managing directors across the industrials, technology, and healthcare verticals. Investment committee decisions require consensus from a subset of senior partners, a governance structure designed to maintain alignment across a partnership that has worked together for decades.

TJC sources the majority of its transactions through a proprietary network of former operators, industry executives, and long-standing intermediary relationships, targeting founder- and family-owned businesses that are not broadly auctioned. The firm's operating affiliate group deepens this advantage by surfacing opportunities through executives who have previously served as TJC portfolio company CEOs.

TJC primarily executes direct control equity investments. The firm does not operate a fund-of-funds program, though its limited partners include institutional allocators that make both fund commitments and co-investments alongside TJC vehicles.

TJC targets mature, cash-flow-positive businesses in the North American middle market, typically with enterprise values between $500 million and $2.5 billion. The firm executes majority buyouts, corporate carve-outs, and public-to-private transactions, avoiding early-stage venture and minority growth equity.

TJC has historically avoided consumer discretionary, media, and financial services, concentrating instead on industrials, transportation and logistics, technology and software, and healthcare services. The partnership has demonstrated a willingness to remain sector-concentrated rather than pursue generalist expansion.

TJC is the direct successor to The Jordan Company, founded by Jay Jordan in 1982. The firm rebranded to TJC in 2023 upon the closing of Resolute Fund VI, reflecting the transition of leadership to a partnership group that no longer includes the founder in day-to-day management.

TJC accommodates limited partner co-investment requests on a deal-by-deal basis, a standard practice among middle-market firms seeking to deepen institutional relationships without diluting economics. The firm does not syndicate minority stakes as a strategic co-investment partner for other sponsors.